ArriVent BioPharma, Inc.(AVBP)
$13.07-0.44 (-3.22%)
AVBP
ArriVent BioPharma, Inc. financials statements
$13.07
At close:-0.44 (-3.22%)
Want to see AVBP full AI Analyst Report?
ArriVent BioPharma, Inc. (AVBP) Income Statement
101 Followers
ArriVent BioPharma, Inc. Income Statement
Last quarter (Q3 2026), ArriVent BioPharma, Inc.'s total revenue was $5.00M. In Q3, ArriVent BioPharma, Inc.'s net income was $-40.31M. See ArriVent BioPharma, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 177.53M | $ 94.31M | $ 74.59M | $ 36.91M | $ 8.70M | |
| Depreciation and Amortization | $ 0.00 | $ 0.00 | $ 0.00 | $ 36.91M | $ 0.00 |
| $ -166.31M | $ -80.49M | $ -69.33M | $ 0.00 | $ -51.61M | |
| $ -177.53M | $ -94.31M | $ -74.59M | $ -36.91M | $ -8.70M | |
| $ 11.23M | $ 13.82M | $ 5.26M | $ 0.00 | $ -42.91M | |
| $ -166.31M | $ -80.49M | $ -69.33M | $ -36.91M | $ -51.61M | |
| $ -166.31M | $ -80.49M | $ -69.33M | $ -36.91M | $ -51.61M | |
| Per Share Metrics | |||||
| Basic EPS | $ -4.32 | $ -2.56 | $ -2.17 | $ -1.10 | $ -40.44 |
| Diluted EPS | $ -4.32 | $ -2.56 | $ -2.17 | $ -1.10 | $ -40.44 |
| Weighted Average Shares Outstanding | 38.46M | 31.47M | 31.96M | 33.49M | 1.28M |
| Weighted Average Shares Outstanding (Diluted) | 38.46M | 31.47M | 31.96M | 33.49M | 1.28M |
Currency in USD
